Global Stein Leventhal Syndrome Drugs Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Stein Leventhal Syndrome Drugs Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Stein Leventhal Syndrome Drugs Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 3.40 Billion
Diagram Market Size (Forecast Year)
USD 5.02 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Pfizer
  • Merck KGaA
  • Sanofi
  • Biocare Medical LLC
  • Lilly

Global Stein Leventhal Syndrome Drugs Market, By Condition (Irregular Periods, Excess Androgen, Polycystic Ovaries, Others), Drug Class (Local Anesthetics, Antidepressants, Anticonvulsants, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Stein Leventhal Syndrome Drugs Market

Stein Leventhal Syndrome Drugs Market Analysis and Size

The global stein leventhal syndrome drugs market is expected to witness significant growth during the forecast period. Even though the exact causes of Stein-Leventhal Syndrome in women is unknown; it is assumed that genetic and environmental factors are the primary reasons for this disorder. Several laboratory-based tests are carried out to analyze the syndrome's reasons, including lipid profile, TSH test, FSH test, and prolactin. COVID-19 also had a major impact on the market growth.

 Data Bridge Market Research analyses a growth rate in the global stein leventhal syndrome drugs market in the forecast period 2022-2029. The expected CAGR of global stein leventhal syndrome drugs market is tend to be around 5% in the mentioned forecast period. The market was valued at USD 3.4 billion in 2021, and it would grow upto USD 5.02 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Stein-Leventhal syndrome, also known as polycystic ovary syndrome (POCS), is a common health problem among females, usually caused by an imbalance of reproductive hormones. Females having POCS may have excess male hormones (androgens) and have infrequent & prolonged irregular menstrual periods. 27% of females can be affected by the POCS during their childbearing years. Besides irregular ovulation, women with Stein-Leventhal syndrome can cause several symptoms such as obesity, acne, hair growth.            

Stein Leventhal Syndrome Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Condition (Irregular Periods, Excess Androgen, Polycystic Ovaries, Others), Drug Class (Local Anesthetics, Antidepressants, Anticonvulsants, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc.(U.S.), Merck KGaA (Germany), Sanofi (France), Biocare Medical, LLC (U.S.), Lilly (U.S.), Teva Pharmaceutical Industries (Israel), Mitsubishi Chemical Group Corporation (U.S.), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (Germany), Par Pharmaceutical (U.S.), TerSera Therapeutics LLC (U.S.), General Electric (U.S.), Koninklijke Philips N.V. (Netherlands), Abbvie,Inc (U..S), Alcon (U.S.), Astellas Pharma Inc. (Japan)

Market Opportunities

  • Increasing Demand for Retail Pharmacies
  • Rise in Fertility Rates

Global Stein Leventhal Syndrome Drugs Market Dynamics

Drivers

  • Increasing Prevalence of PCOS

According to the study published in September 2019, the prevalence of polycystic ovarian syndrome(PCOS) in adolescents was found to be 11.04%, it was 3.39% based on the National Institute of Health’s criteria and 8.03% worldwide based on the Androgen Excess and Polycystic Ovary Syndrome Society.  This boost the market growth.

  • Rising Healthcare Expenditure

Since the last few decades, it has been witnessed that global per capita healthcare spending has improved considerably due to rising rate of awareness associated with the availability of treatments and diagnostic methods for treating various diseases. More and more healthcare spending is likely to result in increasing demand for better diagnostic methods, which in turn, create high growth opportunities for market players operating in the treatment of hormonal infertility.

  • Increasing Growth of Oral Contraceptive Pills

Oral Contraceptive Pills (OCPs) segment is projected to be the fastest growing segment. Commercially available oral contraceptive products mostly include Ethinyl Estradiol, Medroxyprogesterone Acetate, and Drospirenone. These oral contraceptive pills are used for treatment of irregular or absent menstrual cycle, extreme menstrual pain, Premenstrual syndrome (PMS), and acne, which are the usual symptoms of polycystic ovary syndrome. Consequently, demand for these pills is expected to boost the market growth during the forecast period.    

Opportunities

  • Increasing Demand for Retail Pharmacies

The rise in the number of rhinitis therapeutics delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

  • Rising Demands of Insulin Sensitizing Agents

There are various drugs that are used for polycystic ovarian syndrome which are in high demand. Currently, only Metformin, which is an insulin sensitizing agent has been included in the list of reimbursed medicines. All these factors are on the rise and are increasing, thus expanding growth.

 Restraints/Challenges

  • Lack of Female Reproductive Health Awareness

Lack of female reproductive health awareness in most of the economic countries may hamper the market growth. Despite much development and modernization, there is still a lack of awareness associated with reproductive health. There are weird social customs and ignorant behaviors. Thus, this restraints the market growth.

  • High Cost

The huge expenditure associated with the treatment of hormone fertility surely hamper the market growth.

This global stein leventhal syndrome drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global stein leventhal syndrome drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Stein Leventhal Syndrome Drugs Market Scope

The global stein leventhal syndrome drugs market is segmented on the basis of condition, drug class, route of administration , distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Condition

  • Irregular Periods
  • Excess Androgen
  • Polycystic Ovaries
  • Others

Drug Class

  • Local Anesthetics
  • Antidepressants
  • Anticonvulsants
  • Others

Route of Administration

  • Oral
  • Topical
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Stein Leventhal Syndrome Drugs Market Regional Analysis/Insights

The global stein leventhal syndrome drugs market is analysed and market size insights and trends are provided by condition, drug class, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global stein leventhal syndrome drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global stein leventhal syndrome drugs market throughout the forecasted period due to the increase government initiatives and developing healthcare facilities.

North America dominates the market due to the rise cases of reproductive disorders such as Stein-Leventhal syndrome and increase in awareness about the Stein-Leventhal syndrome as well as advanced healthcare facilities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Stein Leventhal Syndrome Drugs MarketShare Analysis

The global stein leventhal syndrome drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global stein leventhal syndrome drugs market.

Key players operating in the global stein leventhal syndrome drugs market include:

  • Pfizer Inc.(U.S.)
  • Merck KGaA (Germany)
  • Sanofi (France)
  • Biocare Medical, LLC (U.S.)
  • Lilly (U.S.)
  • Teva Pharmaceutical Industries (Israel)
  • Mitsubishi Chemical Group Corporation (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • GSK plc. (U.K.)
  • Bayer AG (Germany)
  • Par Pharmaceutical (U.S.)
  • TerSera Therapeutics LLC (U.S.)
  • General Electric (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • Abbvie, Inc (U.S.)
  • Alcon (U.S.)
  • Astellas Pharma Inc. (Japan)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Condition (Irregular Periods, Excess Androgen, Polycystic Ovaries, Others), Drug Class (Local Anesthetics, Antidepressants, Anticonvulsants, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029. .
The Global Stein Leventhal Syndrome Drugs Market size was valued at USD 3.40 USD Billion in 2021.
The Global Stein Leventhal Syndrome Drugs Market is projected to grow at a CAGR of 5% during the forecast period of 2022 to 2029.
The major players operating in the market include Pfizer , Merck KGaA, Sanofi, Biocare Medical LLC, Lilly, Teva Pharmaceutical Industries, Mitsubishi Chemical Group Corporation, BristolMyers Squibb Company, GSK plc, Bayer AG, Par Pharmaceutical, TerSera Therapeutics LLC, General Electric, Koninklijke Philips N.V, Abbvie , Alcon, Astellas Pharma .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.